beta-naphthoflavone has been researched along with Experimental Mammary Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crowell, JA; De Flora, SL; Grubbs, CJ; Heckman, BM; Juliana, MM; Lubet, RA; Steele, VE | 1 |
Beland, FA; Bennett, KK; Bliss, RL; Culp, SJ; Malejka-Giganti, D; Shinozuka, H | 1 |
Mason, ME; Okey, AB | 1 |
Mori, H; Rahman, W; Sugie, S; Suzui, N | 1 |
Bliss, RL; Malejka-Giganti, D; Niehans, GA; Reichert, MA | 1 |
Malejka-Giganti, D; Prigge, WF; Reichert, MA; Ritter, CL | 1 |
6 other study(ies) available for beta-naphthoflavone and Experimental Mammary Neoplasms
Article | Year |
---|---|
Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Aryl Hydrocarbon Hydroxylases; beta-Naphthoflavone; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Epithelial Cells; Female; Indoles; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Transcription, Genetic; Tumor Burden | 2011 |
Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with beta-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; beta-Naphthoflavone; Carcinogens; Cytochrome P-450 Enzyme System; Disease Models, Animal; DNA Adducts; Enzyme Induction; Enzyme Inhibitors; Female; Glucuronosyltransferase; Glutathione Transferase; Liver; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 2005 |
Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Benzoflavones; Benzopyrenes; beta-Naphthoflavone; Breast Neoplasms; Enzyme Induction; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Microsomes; Rats | 1981 |
Chemoprevention of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine-induced mammary carcinogenesis in rats.
Topics: Allyl Compounds; Animals; Anticarcinogenic Agents; Aspirin; Benzoflavones; beta-Naphthoflavone; Carcinogens; Disulfides; Drug Antagonism; Eflornithine; Female; Hydroxybenzoates; Imidazoles; Indoles; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1999 |
Post-initiation treatment of rats with indole-3-carbinol or beta-naphthoflavone does not suppress 7, 12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; beta-Naphthoflavone; Body Weight; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Enzyme Induction; Female; Indoles; Isoenzymes; Mammary Neoplasms, Experimental; Microsomes, Liver; Rats; Rats, Sprague-Dawley | 2000 |
Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
Topics: 17-Hydroxysteroid Dehydrogenases; Animals; beta-Naphthoflavone; Biotransformation; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrone; Female; Indoles; Isoenzymes; Liver; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Microsomes, Liver; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Time Factors; Tissue Distribution | 2001 |